Impact of radiation dose on recurrence in high-risk prostate cancer patients.

Matthew DeekWolfgang A LillebyVictoria VaageKnut H HoleTheodore DeWeeseAndreas StensvoldPhuoc TranTherese Seierstad

Published in: The Prostate (2020)

Prostate dose escalation from 74 to 80 Gy decreases risk of recurrence in high-risk PCa. Further studies are needed to identify the optimal combination of ADT and RT.

Keyphrases

prostate cancer
end stage renal disease
radical prostatectomy
ejection fraction
newly diagnosed
chronic kidney disease
free survival
open label
clinical trial
patient reported outcomes
benign prostatic hyperplasia
double blind